京东知医，阿里氢离子，医疗AI智能体“圈地运动”进入白热化

CACLP体外诊断...01-22

基于美国医学AI智能体OpenEvidence以一年四轮融资、120亿美元估值的亮眼表现，全球资本市场掀起医疗AI热潮，在政策引导、技术突破与市场需求的三重驱动下，中国AI医疗行业正告别单一诊疗场景的探索，迈入以循证医学为核心、覆盖全产业链的多元化创新新阶段。从互联网医疗巨头到专注垂直领域的科技公司，纷纷以“循证医学”为核心，结合本土医疗场景特点，推出了各具特色的AI产品与解决方案，形成了覆盖D端...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2605473430?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-22 09:27","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2605473430","market":"hk","top_or_hot":-1,"title":"京东知医，阿里氢离子，医疗AI智能体“圈地运动”进入白热化","media":"CACLP体外诊断...","content":"<div>\n<p>基于美国医学AI智能体OpenEvidence以一年四轮融资、120亿美元估值的亮眼表现，全球资本市场掀起医疗AI热潮，在政策引导、技术突破与市场需求的三重驱动下，中国AI医疗行业正告别单一诊疗场景的探索，迈入以循证医学为核心、覆盖全产业链的多元化创新新阶段。从互联网医疗巨头到专注垂直领域的科技公司，纷纷以“循证医学”为核心，结合本土医疗场景特点，推出了各具特色的AI产品与解决方案，形成了覆盖D端...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012209315697a2d8f6&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>京东知医，阿里氢离子，医疗AI智能体“圈地运动”进入白热化</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n京东知医，阿里氢离子，医疗AI智能体“圈地运动”进入白热化\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-22 09:27 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012209315697a2d8f6&s=b><strong>CACLP体外诊断...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>基于美国医学AI智能体OpenEvidence以一年四轮融资、120亿美元估值的亮眼表现，全球资本市场掀起医疗AI热潮，在政策引导、技术突破与市场需求的三重驱动下，中国AI医疗行业正告别单一诊疗场景的探索，迈入以循证医学为核心、覆盖全产业链的多元化创新新阶段。从互联网医疗巨头到专注垂直领域的科技公司，纷纷以“循证医学”为核心，结合本土医疗场景特点，推出了各具特色的AI产品与解决方案，形成了覆盖D端...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012209315697a2d8f6&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1770034418.SGD","symbol_name":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012209315697a2d8f6&s=b","article_id":"2605473430","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012209315697a2d8f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2605473430","pubTimestamp":1769045242,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"梅斯医学推出的MedSci则聚焦科研协作场景，通过AI技术简化文献分析、课题设计等流程，成为医生科研工作的“智能搭档”。这些产品的集中涌现，标志着中国医疗AI已从通用型工具向专业化、精准化的循证辅助系统升级。从行业格局来看，以京东健康、阿里健康为代表的互联网医疗巨头，与百度、百川智能等科技企业形成协同竞合态势，推动行业从分散创新向生态化发展演进。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"89618":"京东集团-SWR","LU1770034418.SGD":"ALL CHINA EQUITY \"A\" (SGDHDG) ACC","LU1282649810.SGD":"Allianz Asian Multi Income Plus Cl AMg DIS H2-SGD","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","BK1610":"ETF&股票定投概念","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD","02273":"固生堂","BK1575":"同股不同权","LU0359201885.HKD":"BGF CHINA \"A2\" (HKD) ACC","06618":"京东健康","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU0163747925.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY A ACC","LU0499858602.USD":"NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES \"A\" (USD) ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","IE0032431581.USD":"PINEBRIDGE GREATER CHINA EQUITY \"A\" (USD) ACC","LU1366334651.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"I\" (USD) INC","LU1251922891.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) ACC","SG9999002562.SGD":"LionGlobal Asia Pacific SGD","00241":"阿里健康","LU0594300419.USD":"富达中国消费基金A","LU1770036033.HKD":"NINETY ONE GSF ASIAN EQUITY \"A\" (HKD) ACC","SG9999002828.SGD":"Eastspring Investments Unit Trusts - Dragon Peacock A SGD","LU0650527681.SGD":"Fidelity China Consumer A-SGD","09618":"京东集团-SW","IE00BGV7N243.SGD":"FSSA Global Emerging Markets Focus I Acc SGD","LU1303224171.USD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (USD) INC","LU2257852520.SGD":"JPMorgan Funds - Asia Growth A (acc) SGD","LU0128522157.USD":"TEMPLETON ASIAN GROWTH \"A\" ACC","LU0320764755.SGD":"FTIF - Templeton Asian Growth A Acc SGD","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU0871576103.HKD":"HSBC GIF CHINESE EQUITY \"AC\" (HKD) ACC","LU1282649067.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AMG\" (USD) INC A","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","LU0865486749.SGD":"Eastspring Investments - Asian Equity Income AS SGD-H","LU0469268626.HKD":"AB FCP I-ASIA EX JAPAN EQUITY PTF(AD","LU0499858438.USD":"NINETY ONE GSF ASIA PACIFIC EQUITY OPPORTUNITIES \"A\" (USD) INC","LU1044875133.USD":"天利亚洲反向股票 AU Acc","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","SG9999001226.SGD":"UNITED SUSTAINABLE ASIA TOP 50 \"A\" (SGD) ACC","BK1515":"抗疫概念","LU0259732245.USD":"EASTSPRING INVESTMENTS DRAGON PEACOCK A","LU0029875118.USD":"TEMPLETON ASIAN GROWTH \"A\" INC","LU1328277881.USD":"MANULIFE GF DRAGON GROWTH FUND \"AA\" (USD) INC","LU0828237510.HKD":"SCHRODER ISF BIC (BRAZ IN CH)\"A\" (HKD) ACC","LU0672654166.SGD":"FTIF - Templeton Asian Growth A (acc) SGD-H1","LU0228659784.USD":"施罗德金砖四国基金","BK1502":"双十一","LU0314109678.HKD":"MANULIFE GF DRAGON GROWTH \"AA\" (HKD) INC","LU0370786039.SGD":"Fidelity Greater China A-SGD","LU0543330483.HKD":"TEMPLETON ASIAN GROWTH \"A\" (HKD) ACC","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","LU1044876610.USD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"ZU\" (USD) ACC","BK1501":"阿里概念股","LU1366334578.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"A\" (USD) INC","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU1481107354.HKD":"HSBC GIF HONG KONG EQUITY \"AD\" (HKD) INC","BK1589":"北水核心资产","LU1642822792.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"A\" (SGD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","BK1142":"互联网与直销零售","BK1189":"医疗保健技术","LU1044874839.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"AGH\" (SGDHDG) ACC","BK1617":"AI医疗","LU0164865239.USD":"HSBC GIF CHINESE EQUITY \"AC\" (USD) ACC","LU0084288322.USD":"Natixis Asia Equity RD USD","BK1588":"回港中概股","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1615":"港股-互联网","LU1813983027.USD":"MANULIFE GF DRAGON GROWTH \"AA\" (USD) INC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU1282651121.HKD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (HKD) INC","LU0345775950.USD":"NINETY ONE GSF ASIAN EQUITY \"A\" (USD) ACC","BK1619":"稳定币概念","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0051755006.USD":"摩根大通中国A (dist)","LU0228367735.SGD":"Eastspring Investments - Asian Equity Fund AS SGD","09988":"阿里巴巴-W","LU0164880469.USD":"HSBC GIF HONG KONG EQUITY \"AC\" ACC","LU0588545904.SGD":"Eastspring Investments - Asian Equity Income ASDM SGD","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","BK1249":"综合零售","IE00B3M56506.USD":"NEUBERGER BERMAN EMERGING MARKETS EQUITY \"A\" (USD) ACC","06688":"蚂蚁集团","LU1808992512.USD":"AB ALL CHINA EQUITY PORTFOLIO \"A\" (USD) ACC","LU0588545730.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY INCOME \"ADM\" (USD) INC","LU0431992006.USD":"摩根大通新兴市场机会A（acc）","LU0052750758.USD":"富兰克林中国基金A Acc","LU0531971595.HKD":"HSBC GIF CHINESE EQUITY \"AD\" (HKD) INC","LU0588545490.SGD":"Eastspring Investments - Asian Equity Income AS SGD","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","LU0384037296.USD":"ALLIANZ ASIAN MULTI INCOME PLUS \"AT\" (USD) ACC","LU0488056044.USD":"Allianz Asian Multi Income Plus Cl AM DIS USD","BK1584":"蚂蚁金服概念","BK1571":"互联网医疗","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0345776255.USD":"NINETY ONE GSF ASIAN EQUITY \"A\" (USD) INC","LU1224444064.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AM\" (USDHDG) INC","LU0868486357.SGD":"JPMorgan Funds - Emerging Markets Opportunities A (acc) SGD-H","LU0048580855.USD":"富达大中华区A","LU0315178854.USD":"EASTSPRING INVESTMENTS ASIAN EQUITY INCOME \"A\" ACC","BK1591":"就地过年概念","BK1247":"药品零售","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","LU0293314216.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"A\" (USD) ACC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","IE00B29SXG58.USD":"FSSA CHINA FOCUS \"I\" (USD) ACC","LU0315179316.USD":"EASTSPRING INVESTMENTS ASIAN DYNAMIC \"A\" (USD) ACC","LU0359201612.USD":"贝莱德中国基金A2","LU1282651048.USD":"ALLIANZ GEM EQUITY HIGH DIVIDEND \"AMG\" (USD) INC","LU0348805143.USD":"ALLIANZ ENHANCED ALL CHINA EQUITY \"A\" (USD) INC","LU1720050803.USD":"安联全方位中国股票基金","LU0149721374.USD":"HSBC GIF HONG KONG EQUITY \"AD\" INC","LU0231483743.USD":"abrdn SICAV I - ALL CHINA SUSTAINABLE EQUITY \"A\" (USD) ACC","LU1719994722.HKD":"NINETY ONE GSF ALL CHINA EQUITY \"A\" (HKD) ACC","LU0791590937.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"A\" (USD)"},"translate_title":"JD.com Zhiyi, Alibaba Hydrogen Ion, and the \"enclosure movement\" of medical AI agents have entered a white-hot peak","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"89618":0.6,"00241":0.9,"06618":1.94,"09988":0.9,"09618":0.9,"06688":0.9,"02273":0.9},"content_text":"基于美国医学AI智能体OpenEvidence以一年四轮融资、120亿美元估值的亮眼表现，全球资本市场掀起医疗AI热潮，在政策引导、技术突破与市场需求的三重驱动下，中国AI医疗行业正告别单一诊疗场景的探索，迈入以循证医学为核心、覆盖全产业链的多元化创新新阶段。从互联网医疗巨头到专注垂直领域的科技公司，纷纷以“循证医学”为核心，结合本土医疗场景特点，推出了各具特色的AI产品与解决方案，形成了覆盖D端（医生）、C端（患者）、B端（医疗机构）的全链条服务体系。D端医生服务：循证工具重构临床科研流程京东健康在2026年度医生盛典上发布的“知医”，被业界视为OpenEvidence的中国版方案，其整合超4000万份文献、4万份指南及3万份药品说明书的核心资源，构建起AI临床决策防火墙，全面集成于京东医生App并向全体医生开放，实现了医学知识检索与临床决策辅助的无缝衔接。阿里健康同期推出的自研医学大模型“氢离子”，则以“低幻觉、高循证”为核心卖点，所有回答均具备权威出处与一键溯源功能，致力于成为医疗领域幻觉率最低的AI助手，填补了国内严肃医疗场景下高可信AI工具的空白。在垂直领域，医赋科技的Info X Med以“医学文献数据库+AI智能体”为技术底座，整合全球4000万篇医学文献及威立等顶级出版商资源，全文PDF收录率高达95%，更侧重中国人群本土化研究数据的整合，探索出贴合中国医生工作流的创新路径。梅斯医学推出的MedSci则聚焦科研协作场景，通过AI技术简化文献分析、课题设计等流程，成为医生科研工作的“智能搭档”。这些产品的集中涌现，标志着中国医疗AI已从通用型工具向专业化、精准化的循证辅助系统升级。C端健康服务：AI拉近医患信息鸿沟在患者端，AI健康助手正从简单的症状查询向全周期健康管理演进。百川智能于2026年1月开源的新一代医疗大模型Baichuan-M3，在全球权威医疗AI评测HealthBench中以65.1分的综合成绩位列第一，其3.5%的全球最低幻觉率，通过将事实一致性约束融入模型训练阶段实现，首次具备了原生“端到端”严肃问诊能力。百川智能明确聚焦院外C端市场，通过旗下应用“百小应”帮助患者系统理解诊疗逻辑，有效缩短医患信息差。蚂蚁集团升级推出的AI健康助手“蚂蚁阿福”，则以“AI健康朋友”为定位，整合健康管理、报告解读、在线问诊等一站式服务，让普通用户也能便捷获取专业健康指导。临床诊疗辅助：技术突破赋能基层医疗在临床诊疗领域，国内企业的探索更注重与本土医疗资源分布特点相结合。医联发布的MedGPT大语言模型，历经多轮临床验证，2025年在CSEDB测评中以0.895分位列世界第一，成为唯一在安全性评分突破0.9的模型，其每月1.2%-1.5%的准确率提升速度，使其在基层医疗场景中具备极高应用价值。百度灵医bot则依托文心大模型技术，整合全国800余家医院及4000多家基层诊疗机构的服务经验，构建起覆盖万级医学书籍与亿级科普内容的知识图谱，通过智能分诊、病历质控等功能，成为连接优质医疗资源与基层机构的重要桥梁，更与固生堂达成战略合作，开创了中医药领域大模型应用的先河。中国AI医疗行业的创新实践，正在重塑医疗服务的底层逻辑。从医生端来看，AI循证工具将原本需要数小时的文献检索与分析工作缩短至分钟级，使医生能够将更多精力投入到患者照护中；从患者端来看，AI健康助手打破了优质医疗知识的获取壁垒，推动医疗服务从单次诊疗向长期健康管理延伸。从行业格局来看，以京东健康、阿里健康为代表的互联网医疗巨头，与百度、百川智能等科技企业形成协同竞合态势，推动行业从分散创新向生态化发展演进。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2605473430","isCrawlerRequest":true}